1. Lessons from Lipitor and the broken blockbuster drug model;The Lancet (in-house editorial);Lancet,2011
2. International Monetary Fund World Economic Outlook Database 2011 www.imf.org/external/pubs/ft/weo/2011/02/weodata/index.aspx
3. The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing and depth of evidence;Ioannidis;BMJ,2010
4. Abbott 2009 Annual Report 2009 http://www.abbott.com/annual-reports/2009/downloads/Editorial_section_only.pdf
5. MassDevice staff MassDevice Blog: Abbott Labs and Boston Scientific together make up about 64 percent of U.S. drug eluting stent market http://www.massdevice.com/news/abbott-and-boston-scientific-dominate-46-billion-drug-eluting-stent-market